Dibenzazepine Agents in Epilepsy: How Does Eslicarbazepine Acetate Differ?

Charlotte Lawthom; Jukka Peltola; Rob McMurray; Emma Dodd; Vicente Villanueva

doi:10.1007/s40120-018-0111-2

Dibenzazepine Agents in Epilepsy: How Does Eslicarbazepine Acetate Differ?

Charlotte Lawthom, Jukka Peltola, Rob McMurray, Emma Dodd, Vicente Villanueva

Department of Neurosciences and Rehabilitation

Research output: Contribution to journal › Article › Scientific › peer-review

13 Citations (Scopus)

Original language	English
Pages (from-to)	195-20
Journal	Neurology and therapy
Volume	7
Issue number	2
DOIs	https://doi.org/10.1007/s40120-018-0111-2
Publication status	Published - 2018
Publication type	A1 Journal article-refereed

Keywords

Antiepileptic drug
Carbamazepine
Dibenzazepine
Epilepsy
Eslicarbazepine acetate
Oxcarbazepine

Publication forum classification

Publication forum level 0

Access to Document

10.1007/s40120-018-0111-2

http://urn.fi/urn:nbn:fi:uta-201901041057

Cite this

@article{ef71ff11b04c4924b97913cc35e85e2c,

title = "Dibenzazepine Agents in Epilepsy: How Does Eslicarbazepine Acetate Differ?",

keywords = "Antiepileptic drug, Carbamazepine, Dibenzazepine, Epilepsy, Eslicarbazepine acetate, Oxcarbazepine, Antiepileptic drug, Carbamazepine, Dibenzazepine, Epilepsy, Eslicarbazepine acetate, Oxcarbazepine",

author = "Charlotte Lawthom and Jukka Peltola and Rob McMurray and Emma Dodd and Vicente Villanueva",

year = "2018",

doi = "10.1007/s40120-018-0111-2",

language = "English",

volume = "7",